Logo image of ICOS.MI

INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:ICOS - IT0005455875 - Common Stock

11.1 EUR
+0.04 (+0.36%)
Last: 12/19/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ICOS. ICOS was compared to 14 industry peers in the Personal Care Products industry. ICOS has an average financial health and profitability rating. While showing a medium growth rate, ICOS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ICOS was profitable.
In the past year ICOS had a positive cash flow from operations.
In the past 5 years ICOS has always been profitable.
ICOS had a positive operating cash flow in each of the past 5 years.
ICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

ICOS has a Return On Assets (4.71%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 10.16%, ICOS is in line with its industry, outperforming 42.86% of the companies in the same industry.
With a Return On Invested Capital value of 9.59%, ICOS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
ICOS had an Average Return On Invested Capital over the past 3 years of 9.32%. This is below the industry average of 11.79%.
The last Return On Invested Capital (9.59%) for ICOS is above the 3 year average (9.32%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.71%
ROE 10.16%
ROIC 9.59%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ICOS.MI Yearly ROA, ROE, ROICICOS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of ICOS (4.34%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ICOS has declined.
ICOS has a Operating Margin of 9.31%. This is comparable to the rest of the industry: ICOS outperforms 50.00% of its industry peers.
In the last couple of years the Operating Margin of ICOS has declined.
With a Gross Margin value of 19.84%, ICOS is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ICOS has declined.
Industry RankSector Rank
OM 9.31%
PM (TTM) 4.34%
GM 19.84%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
ICOS.MI Yearly Profit, Operating, Gross MarginsICOS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ICOS is still creating some value.
The number of shares outstanding for ICOS remains at a similar level compared to 1 year ago.
ICOS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ICOS has a worse debt to assets ratio.
ICOS.MI Yearly Shares OutstandingICOS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICOS.MI Yearly Total Debt VS Total AssetsICOS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ICOS has an Altman-Z score of 3.34. This indicates that ICOS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.34, ICOS is in line with its industry, outperforming 42.86% of the companies in the same industry.
ICOS has a debt to FCF ratio of 16.66. This is a negative value and a sign of low solvency as ICOS would need 16.66 years to pay back of all of its debts.
The Debt to FCF ratio of ICOS (16.66) is worse than 85.71% of its industry peers.
ICOS has a Debt/Equity ratio of 0.52. This is a neutral value indicating ICOS is somewhat dependend on debt financing.
ICOS has a Debt to Equity ratio (0.52) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 16.66
Altman-Z 3.34
ROIC/WACC1.45
WACC6.62%
ICOS.MI Yearly LT Debt VS Equity VS FCFICOS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

ICOS has a Current Ratio of 1.67. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
ICOS has a better Current ratio (1.67) than 78.57% of its industry peers.
A Quick Ratio of 1.03 indicates that ICOS should not have too much problems paying its short term obligations.
ICOS has a Quick ratio of 1.03. This is in the better half of the industry: ICOS outperforms 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.03
ICOS.MI Yearly Current Assets VS Current LiabilitesICOS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.80% over the past year.
Measured over the past 5 years, ICOS shows a small growth in Earnings Per Share. The EPS has been growing by 1.57% on average per year.
ICOS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.02%.
ICOS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.36% yearly.
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%

3.2 Future

ICOS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.03% yearly.
The Revenue is expected to grow by 1.81% on average over the next years.
EPS Next Y4.9%
EPS Next 2Y11.54%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue Next Year0.74%
Revenue Next 2Y3.1%
Revenue Next 3Y3.95%
Revenue Next 5Y1.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICOS.MI Yearly Revenue VS EstimatesICOS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ICOS.MI Yearly EPS VS EstimatesICOS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.65, which indicates a rather expensive current valuation of ICOS.
The rest of the industry has a similar Price/Earnings ratio as ICOS.
ICOS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.38, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 14.09, which indicates a correct valuation of ICOS.
ICOS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ICOS is cheaper than 78.57% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.83, ICOS is valued a bit cheaper.
Industry RankSector Rank
PE 22.65
Fwd PE 14.09
ICOS.MI Price Earnings VS Forward Price EarningsICOS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICOS is valued a bit cheaper than 71.43% of the companies in the same industry.
ICOS's Price/Free Cash Flow ratio is rather expensive when compared to the industry. ICOS is more expensive than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 68.29
EV/EBITDA 7.61
ICOS.MI Per share dataICOS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ICOS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ICOS's earnings are expected to grow with 12.03% in the coming years.
PEG (NY)4.62
PEG (5Y)14.42
EPS Next 2Y11.54%
EPS Next 3Y12.03%

3

5. Dividend

5.1 Amount

ICOS has a Yearly Dividend Yield of 1.81%.
Compared to an average industry Dividend Yield of 2.16, ICOS has a dividend in line with its industry peers.
ICOS's Dividend Yield is comparable with the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

38.09% of the earnings are spent on dividend by ICOS. This is a low number and sustainable payout ratio.
DP38.09%
EPS Next 2Y11.54%
EPS Next 3Y12.03%
ICOS.MI Yearly Income VS Free CF VS DividendICOS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICOS.MI Dividend Payout.ICOS.MI Dividend Payout, showing the Payout Ratio.ICOS.MI Dividend Payout.PayoutRetained Earnings

INTERCOS SPA

BIT:ICOS (12/19/2025, 7:00:00 PM)

11.1

+0.04 (+0.36%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-02 2026-03-02/amc
Inst Owners36.58%
Inst Owner ChangeN/A
Ins Owners32.17%
Ins Owner ChangeN/A
Market Cap1.07B
Revenue(TTM)1.09B
Net Income(TTM)47.30M
Analysts85
Price Target16.87 (51.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP38.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.96%
PT rev (3m)-2.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.27%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.09%
Revenue NY rev (3m)-1.9%
Valuation
Industry RankSector Rank
PE 22.65
Fwd PE 14.09
P/S 0.98
P/FCF 68.29
P/OCF 11.95
P/B 2.3
P/tB 4.02
EV/EBITDA 7.61
EPS(TTM)0.49
EY4.41%
EPS(NY)0.79
Fwd EY7.1%
FCF(TTM)0.16
FCFY1.46%
OCF(TTM)0.93
OCFY8.36%
SpS11.31
BVpS4.83
TBVpS2.76
PEG (NY)4.62
PEG (5Y)14.42
Graham Number7.3
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 10.16%
ROCE 14.65%
ROIC 9.59%
ROICexc 11.59%
ROICexgc 17.27%
OM 9.31%
PM (TTM) 4.34%
GM 19.84%
FCFM 1.44%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ROICexc(3y)12.89%
ROICexc(5y)11.65%
ROICexgc(3y)22.3%
ROICexgc(5y)20.57%
ROCE(3y)14.06%
ROCE(5y)12.06%
ROICexgc growth 3Y0.58%
ROICexgc growth 5Y-13.66%
ROICexc growth 3Y4.35%
ROICexc growth 5Y-9.88%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
F-Score7
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 16.66
Debt/EBITDA 1.6
Cap/Depr 144.42%
Cap/Sales 6.77%
Interest Coverage 11.2
Cash Conversion 58.65%
Profit Quality 33.11%
Current Ratio 1.67
Quick Ratio 1.03
Altman-Z 3.34
F-Score7
WACC6.62%
ROIC/WACC1.45
Cap/Depr(3y)119.92%
Cap/Depr(5y)113.2%
Cap/Sales(3y)5.7%
Cap/Sales(5y)5.95%
Profit Quality(3y)77.95%
Profit Quality(5y)89.83%
High Growth Momentum
Growth
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
EPS Next Y4.9%
EPS Next 2Y11.54%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%
Revenue Next Year0.74%
Revenue Next 2Y3.1%
Revenue Next 3Y3.95%
Revenue Next 5Y1.81%
EBIT growth 1Y16.33%
EBIT growth 3Y15.34%
EBIT growth 5Y2.71%
EBIT Next Year72.73%
EBIT Next 3Y26.54%
EBIT Next 5YN/A
FCF growth 1Y-69.82%
FCF growth 3Y14.23%
FCF growth 5Y-3.11%
OCF growth 1Y-14.11%
OCF growth 3Y17%
OCF growth 5Y3.39%

INTERCOS SPA / ICOS.MI FAQ

What is the ChartMill fundamental rating of INTERCOS SPA (ICOS.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ICOS.MI.


What is the valuation status of INTERCOS SPA (ICOS.MI) stock?

ChartMill assigns a valuation rating of 3 / 10 to INTERCOS SPA (ICOS.MI). This can be considered as Overvalued.


How profitable is INTERCOS SPA (ICOS.MI) stock?

INTERCOS SPA (ICOS.MI) has a profitability rating of 4 / 10.


Can you provide the financial health for ICOS stock?

The financial health rating of INTERCOS SPA (ICOS.MI) is 4 / 10.


What is the expected EPS growth for INTERCOS SPA (ICOS.MI) stock?

The Earnings per Share (EPS) of INTERCOS SPA (ICOS.MI) is expected to grow by 4.9% in the next year.